Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
31.73
+2.02 (6.80%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Akero Therapeutics Statistics

Total Valuation

AKRO has a market cap or net worth of $2.20 billion. The enterprise value is $1.39 billion.

Market Cap 2.20B
Enterprise Value 1.39B

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date Nov 11, 2024
Ex-Dividend Date n/a

Share Statistics

AKRO has 69.43 million shares outstanding. The number of shares has increased by 30.11% in one year.

Shares Outstanding 69.43M
Shares Change (YoY) +30.11%
Shares Change (QoQ) +16.61%
Owned by Insiders (%) 1.75%
Owned by Institutions (%) 91.14%
Float 55.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.75
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 24.89, with a Debt / Equity ratio of 0.05.

Current Ratio 24.89
Quick Ratio 24.39
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -58.44

Financial Efficiency

Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -19.83%.

Return on Equity (ROE) -28.87%
Return on Assets (ROA) -19.15%
Return on Capital (ROIC) -19.83%
Revenue Per Employee n/a
Profits Per Employee -$3.65M
Employee Count 56
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +178.82% in the last 52 weeks. The beta is -0.26, so AKRO's price volatility has been lower than the market average.

Beta (5Y) -0.26
52-Week Price Change +178.82%
50-Day Moving Average 28.03
200-Day Moving Average 24.46
Relative Strength Index (RSI) 64.21
Average Volume (20 Days) 465,653

Short Selling Information

The latest short interest is 4.72 million, so 6.79% of the outstanding shares have been sold short.

Short Interest 4.72M
Short Previous Month 6.77M
Short % of Shares Out 6.79%
Short % of Float 8.57%
Short Ratio (days to cover) 8.67

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -234.18M
Pretax Income -204.18M
Net Income -204.18M
EBITDA -234.17M
EBIT -234.18M
Earnings Per Share (EPS) -$3.40
Full Income Statement

Balance Sheet

The company has $760.19 million in cash and $35.91 million in debt, giving a net cash position of $812.41 million or $11.70 per share.

Cash & Cash Equivalents 760.19M
Total Debt 35.91M
Net Cash 812.41M
Net Cash Per Share $11.70
Equity (Book Value) 798.07M
Book Value Per Share 11.53
Working Capital 744.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$190.94 million and capital expenditures -$999,000, giving a free cash flow of -$191.94 million.

Operating Cash Flow -190.94M
Capital Expenditures -999,000
Free Cash Flow -191.94M
FCF Per Share -$2.76
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AKRO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -30.11%
Shareholder Yield -30.11%
Earnings Yield -9.27%
FCF Yield -8.71%
Dividend Details

Analyst Forecast

The average price target for AKRO is $43.20, which is 36.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target $43.20
Price Target Difference 36.15%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1